{"id":926881,"date":"2026-01-13T09:25:59","date_gmt":"2026-01-13T14:25:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/"},"modified":"2026-01-13T09:25:59","modified_gmt":"2026-01-13T14:25:59","slug":"picard-syncardia-featured-on-the-cruxx-of-medtech-podcast","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/","title":{"rendered":"Picard \/ SynCardia Featured on the Cruxx of MedTech Podcast"},"content":{"rendered":"
\n

TUCSON, Ariz., Jan. 13, 2026 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (\u201cPicard\u201d or the \u201cCompany\u201d), parent company of SynCardia Systems LLC, maker of the world\u2019s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced the launch of the Cruxx to MedTech Podcast discussing series exploring the SynCardia Total Artificial Heart (STAH) and the next generation, fully implantable Emperor device through the lens of patients and management.<\/p>\n

Anchored by a powerful patient survival story, the series highlights the real-world impact of the STAH on patients facing end stage heart failure. The discussion then turns to SynCardia System\u2019s \/ Picard Medical\u2019s CEO, Patrick NJ Schnegelsberg who outlines the Company\u2019s STAH platform and its next generation fully implantable Emperor system. Management highlights the clear differentiation of STAH compared to other approaches, the Company\u2019s long-term vision to create a true alternative to heart transplantation, and the significant commercial opportunity driven by the global shortage of donor hearts.<\/p>\n

The podcast will be available for download and streaming on all major platforms, including Apple Podcasts, Spotify, and Google Podcasts and available directly on Cruxx\u2019s website here: https:\/\/www.thisiscruxx.com\/content-hub\/<\/a><\/p>\n

\n About Cruxx<\/strong>\n <\/p>\n

Cruxx is a medical technology search and capital advisory firm on a mission to place MedTech pioneers in transformative roles that help people live longer. With a focus on critical fields such as cardiovascular, surgical robotics, neurotechnology, AI, and digital health, Cruxx partners with founders, executives, and investors to build leadership teams and accelerate life-changing innovation.\u00a0For information, visit:\u00a0 www.thisiscruxx.com<\/strong><\/a><\/p>\n

\n About Picard Medical and SynCardia<\/strong>\n <\/p>\n

Picard Medical, Inc. is the parent company of SynCardia Systems, LLC (\u201cSynCardia\u201d), the Tucson, Arizona\u2013based leader with the only commercially available total artificial heart technology for patients with end-stage heart failure. SynCardia develops, manufactures, and commercializes the SynCardia Total Artificial Heart (\u201cSTAH\u201d), an implantable system that assumes the full functions of a failing or failed human heart. It is the first artificial heart approved by both the FDA and Health Canada, and it remains the only commercially available artificial heart in the United States and Canada. With more than 2,100 implants performed at hospitals across 27 countries, the SynCardia Total Artificial Heart is the most widely used and extensively studied artificial heart in the world.<\/p>\n

For additional information about Picard Medical, please visit\u00a0www.picardmedical.com<\/a>\u00a0or review the Company\u2019s filings with the U.S. Securities and Exchange Commission at\u00a0www.sec.gov<\/a>.<\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company\u2019s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Registration Statement and related prospectus filed in connection with the initial public offering with the SEC. Copies are available on the SEC\u2019s website,\u00a0http:\/\/www.sec.gov<\/a>.<\/p>\n

\n Contact:<\/strong>\n <\/p>\n

\n Investors<\/u>
\n
Eric Ribner
Managing Director
LifeSci Advisors LLC
eric@lifesciadvisors.com<\/a><\/p>\n

\n Picard Medical, Inc.\/SynCardia Systems, LLC<\/u>
\n
\n IR@picardmedical.com<\/a>\n <\/p>\n

\n General\/Media<\/u>
\n
Brittany Lanza
blanza@syncardia.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

TUCSON, Ariz., Jan. 13, 2026 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (\u201cPicard\u201d or the \u201cCompany\u201d), parent company of SynCardia Systems LLC, maker of the world\u2019s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced the launch of the Cruxx to MedTech Podcast discussing series exploring the SynCardia Total Artificial Heart (STAH) and the next generation, fully implantable Emperor device through the lens of patients and management. Anchored by a powerful patient survival story, the series highlights the real-world impact of the STAH on patients facing end stage heart failure. The discussion then turns to SynCardia System\u2019s \/ Picard Medical\u2019s CEO, Patrick NJ Schnegelsberg who outlines the Company\u2019s STAH platform and its … <\/p>\n

Continue reading “Picard \/ SynCardia Featured on the Cruxx of MedTech Podcast”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-926881","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPicard \/ SynCardia Featured on the Cruxx of MedTech Podcast - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Picard \/ SynCardia Featured on the Cruxx of MedTech Podcast - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TUCSON, Ariz., Jan. 13, 2026 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (\u201cPicard\u201d or the \u201cCompany\u201d), parent company of SynCardia Systems LLC, maker of the world\u2019s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced the launch of the Cruxx to MedTech Podcast discussing series exploring the SynCardia Total Artificial Heart (STAH) and the next generation, fully implantable Emperor device through the lens of patients and management. Anchored by a powerful patient survival story, the series highlights the real-world impact of the STAH on patients facing end stage heart failure. The discussion then turns to SynCardia System\u2019s \/ Picard Medical\u2019s CEO, Patrick NJ Schnegelsberg who outlines the Company\u2019s STAH platform and its … Continue reading "Picard \/ SynCardia Featured on the Cruxx of MedTech Podcast"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-13T14:25:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNDUxOSM3MzU3OTEzIzUwMDE1MDk2Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Picard \\\/ SynCardia Featured on the Cruxx of MedTech Podcast\",\"datePublished\":\"2026-01-13T14:25:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/\"},\"wordCount\":590,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyNDUxOSM3MzU3OTEzIzUwMDE1MDk2Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/\",\"name\":\"Picard \\\/ SynCardia Featured on the Cruxx of MedTech Podcast - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyNDUxOSM3MzU3OTEzIzUwMDE1MDk2Ng==\",\"datePublished\":\"2026-01-13T14:25:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyNDUxOSM3MzU3OTEzIzUwMDE1MDk2Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyNDUxOSM3MzU3OTEzIzUwMDE1MDk2Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Picard \\\/ SynCardia Featured on the Cruxx of MedTech Podcast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Picard \/ SynCardia Featured on the Cruxx of MedTech Podcast - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/","og_locale":"en_US","og_type":"article","og_title":"Picard \/ SynCardia Featured on the Cruxx of MedTech Podcast - Market Newsdesk","og_description":"TUCSON, Ariz., Jan. 13, 2026 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (\u201cPicard\u201d or the \u201cCompany\u201d), parent company of SynCardia Systems LLC, maker of the world\u2019s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced the launch of the Cruxx to MedTech Podcast discussing series exploring the SynCardia Total Artificial Heart (STAH) and the next generation, fully implantable Emperor device through the lens of patients and management. Anchored by a powerful patient survival story, the series highlights the real-world impact of the STAH on patients facing end stage heart failure. The discussion then turns to SynCardia System\u2019s \/ Picard Medical\u2019s CEO, Patrick NJ Schnegelsberg who outlines the Company\u2019s STAH platform and its … Continue reading \"Picard \/ SynCardia Featured on the Cruxx of MedTech Podcast\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-13T14:25:59+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNDUxOSM3MzU3OTEzIzUwMDE1MDk2Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Picard \/ SynCardia Featured on the Cruxx of MedTech Podcast","datePublished":"2026-01-13T14:25:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/"},"wordCount":590,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNDUxOSM3MzU3OTEzIzUwMDE1MDk2Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/","name":"Picard \/ SynCardia Featured on the Cruxx of MedTech Podcast - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNDUxOSM3MzU3OTEzIzUwMDE1MDk2Ng==","datePublished":"2026-01-13T14:25:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNDUxOSM3MzU3OTEzIzUwMDE1MDk2Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyNDUxOSM3MzU3OTEzIzUwMDE1MDk2Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-syncardia-featured-on-the-cruxx-of-medtech-podcast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Picard \/ SynCardia Featured on the Cruxx of MedTech Podcast"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/926881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=926881"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/926881\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=926881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=926881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=926881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}